Eu Regulator

EU Finds Rare Eye Risks in Ozempic and Other GLP-1 Diabetes Drugs

The EU drugs regulator has identified a 'very rare' side effect of Ozempic, which can cause sight loss, highlighting the importance of monitoring adverse effects of medications.